1. Integrative Analysis of MUC4 to Prognosis and Immune Infiltration in Pan-Cancer: Friend or Foe?
   Xiao-Peng Gao et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
2. FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway
   Chao Liu et al, 2020, Cancer Letters CrossRef
3. Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating Cancer
   Bo Lin et al, 2021, Frontiers in Oncology CrossRef
4. Superparamagnetic iron oxide nanoparticles target BxPC-3 cells and silence MUC4 for the treatment of pancreatic cancer
   Yu Pu et al, 2023, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
5. MUC4 isoforms expression profiling and prognosis value in Chinese melanoma patients
   Jinyu Yu et al, 2020, Clinical and Experimental Medicine CrossRef
6. Cancer immune exclusion: breaking the barricade for a successful immunotherapy
   Sofia Bruni et al, 2023, Frontiers in Oncology CrossRef
7. Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression
   Saravanakumar Marimuthu et al, 2021, Cancer and Metastasis Reviews CrossRef
8. TAM-derived extracellular vesicles containing microRNA-29a-3p explain the deterioration of ovarian cancer
   Lili Lu et al, 2021, Molecular Therapy - Nucleic Acids CrossRef
9. Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness
   Tania Gamberi et al, 2022, Medicinal Research Reviews CrossRef
10. Cell origin and genome profile difference of penoscrotum invasive extramammary Paget disease compared with its in situ counterpart
    Yamin Rao et al, 2022, Frontiers in Oncology CrossRef
11. Auranofin sensitizes breast cancer cells to paclitaxel mediated cell death via regulating FOXO3/Nrf2/Keap1 signaling pathway
    N. Deepika et al, 2024, Cell Biochemistry and Function CrossRef